Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125571461 | 12557146 | 1 | I | 201607 | 20160711 | 20160714 | 20160714 | EXP | US-GLAXOSMITHKLINE-US2016099061 | GLAXOSMITHKLINE | 60.46 | YR | F | Y | 0.00000 | 20160714 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125571461 | 12557146 | 1 | PS | WELLBUTRIN SR | BUPROPION HYDROCHLORIDE | 1 | 150 MG, BID | U | 20358 | 150 | MG | PROLONGED-RELEASE TABLET | BID | ||||||
| 125571461 | 12557146 | 2 | C | XANAX | ALPRAZOLAM | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125571461 | 12557146 | 1 | Depression |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125571461 | 12557146 | Anxiety | |
| 125571461 | 12557146 | Flat affect | |
| 125571461 | 12557146 | Hyperhidrosis | |
| 125571461 | 12557146 | Insomnia | |
| 125571461 | 12557146 | Migraine | |
| 125571461 | 12557146 | Somnolence | |
| 125571461 | 12557146 | Tremor |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125571461 | 12557146 | 1 | 201607 | 0 |